Page last updated: 2024-08-23

nimustine and Multiple Myeloma

nimustine has been researched along with Multiple Myeloma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's1 (12.50)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldacci, E; Capria, S; de Propris, MS; Meloni, G; Petrucci, MT; Pulsoni, A; Ribersani, M1
Console, G; Iacopino, P; Irrera, G; Martino, M; Massara, E; Messina, G; Praticò, G1
Barale, R; Buda, G; Conidi, E; Galimberti, S; Genestreti, G; Giuliani, N; Iacopino, P; Maggini, V; Morabito, F; Petrini, M; Rizzoli, V; Rossi, AM1
Fujiwara, Y; Furukawa, K; Hirota, Y; Nakaide, Y; Tanaka, M1
Kashiwazaki, S; Nishinarita, M; Sugai, S1
Ishii, H1
Oguro, M; Sakai, C; Takagi, T1
Akutsu, M; Hoshino, S; Saito, H; Shiozaki, H; Takada, K; Takanashi, M; Takei, Y; Tanaka, S; Teramura, M; Wada, M1

Trials

2 trial(s) available for nimustine and Multiple Myeloma

ArticleYear
Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients.
    European journal of haematology, 2006, Volume: 77, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Humans; Infection Control; Infections; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Neutropenia; Nimustine; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins; Recovery of Function; Time Factors; Transplantation, Autologous; Vincristine

2006
Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms.
    Leukemia research, 2008, Volume: 32, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Female; Glutathione S-Transferase pi; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Nimustine; Polymorphism, Single Nucleotide; Stem Cell Transplantation; Survival Analysis; Thymidylate Synthase; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

2008

Other Studies

6 other study(ies) available for nimustine and Multiple Myeloma

ArticleYear
High-dose idarubicin, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma responsive to DAV chemotherapy: comparison with a historical control.
    Acta haematologica, 2006, Volume: 115, Issue:1-2

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Dacarbazine; Female; Graft Survival; Humans; Idarubicin; Infections; Male; Melphalan; Middle Aged; Mucositis; Multiple Myeloma; Neutropenia; Nimustine; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Vincristine

2006
[Trial of combination chemotherapy for multiple myeloma and macroglobulinemia--VENAP therapy (author's transl)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1980, Volume: 21, Issue:11

    Topics: Aged; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Myeloma; Nimustine; Nitrosourea Compounds; Prednisolone; Procarbazine; Vincristine; Waldenstrom Macroglobulinemia

1980
[Monoclonal rheumatoid factor in a patient with multiple myeloma after chemotherapy].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 1996, Volume: 19, Issue:5

    Topics: Aged; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Connectin; Cyclophosphamide; Female; Humans; Immunoglobulin A; Immunoglobulin Idiotypes; Melphalan; Multiple Myeloma; Muscle Proteins; Myeloma Proteins; Nimustine; Prednisolone; Rheumatoid Factor; Vincristine

1996
Combination chemotherapy for multiple myeloma with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine.
    Acta medica Okayama, 1988, Volume: 42, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Female; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Nimustine; Nitrosourea Compounds; Prednisolone; Prognosis; Vincristine

1988
[Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1986, Volume: 27, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Melphalan; Multiple Myeloma; Nimustine; Nitrosourea Compounds; Prednisolone; Vincristine

1986
[Comparative studies of intermittent melphalan and prednisolone (MP) versus 5-drug regimen (QUVMP) and 3-drug regimen (QUP) in multiple myeloma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1987, Volume: 28, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Urea Nitrogen; Carbazilquinone; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Nimustine; Nitrosourea Compounds; Prednisolone; Prognosis; Risk; Vincristine

1987